EcoDrugPlus

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSMMDG00005012533
Gene Symbol: MMP14A
1 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSMMDG00005024236
Gene Symbol: MMP14B
1 Cross references
196 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSMMDG00005023645
Gene Symbol: MMP2
1 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSMMDG00005020423
Gene Symbol: MMP9
3 Cross references
215 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSMMDG00005022828
Gene Symbol: MTOR
3 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSMMDG00005010547
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSMMDG00005012242
Gene Symbol: MC4R
1 Cross references
89 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSMMDG00005000387
Gene Symbol: MTNR1AA
1 Cross references
186 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSMMDG00005014047
Gene Symbol: MME
1 Cross references
236 Possible Orthologues:

Metabotropic Glutamate Receptor 2-Like

Ensembl ID : ENSMMDG00005004629
Gene Symbol: LOC115359582
3 Cross references
206 Possible Orthologues:

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSMMDG00005017455
Gene Symbol: LOC115360302
3 Cross references
215 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSMMDG00005018690
Gene Symbol: METAP2
1 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).